Sagility India Limited — Investor Meet, 10-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** Sagility India Limited reported strong financial results with Q3 FY25 revenues reaching ₹14,531 million, reflecting a year-on-year growth of 15.3% in INR terms (14% in constant currency). The quarter saw a 9.7% sequential increase, driven mainly by the Payer vertical's 13.1% growth and a notable 38% growth in the Provider sector, which together helped the company achieve an adjusted EBITDA of ₹4,567 million, representing a robust EBITDA margin of 31.4%. Adjusted profit after tax stood at ₹2,626 million, up 67.6% year-on-year.

2. **Future Outlook and Growth Drivers:** Management expressed confidence in continuing growth, anticipating similar annual growth rates as YTD results due to strong client relationships and operational excellence. The acquisition of BroadPath is expected to enhance market presence and contribute positively to earnings.

3. **Order Book and Operational Updates:** The company indicated healthy client engagement, particularly during the open enrollment period, which traditionally drives higher volumes and revenues. The recent acquisition of BroadPath expands Sagility's service capabilities and client base.

4. **Analyst Q&A Insights (Detailed):**

- **Revenue and Profitability:** Analysts noted revenues surpassed expectations, driven by seasonal factors and strong client demand. Management confirmed that the seasonality effect is temporary and should not overshadow the year-on-year performance.

- **Market Position and Competitive Landscape:** Management highlighted the unique position as a healthcare-only firm, differentiating Sagility from competitors. They acknowledged ongoing competition from larger BPM firms and expressed confidence in maintaining a competitive edge through recent acquisitions.

- **Operational Challenges or Risks:** Discussion around currency sensitivity indicated that while some fluctuations could affect margins, the current hedging strategies provide adequate protection against significant risks.

- **Capex and Capital Allocation:** Analysts confirmed that cash generation supports investment in growth while allowing for debt reduction—net debt to trailing EBITDA stands at 0.55x, showcasing a strong balance sheet.

- **Strategic Priorities and Long-Term Vision:** Ongoing focus on innovation, expanding client services, and strategic acquisitions are emphasized as crucial for future growth.

5. **Market or Regulatory Updates:** Management remains vigilant regarding potential regulatory impacts in the healthcare sector but noted no immediate concerns from recent governance changes in the U.S.

6. **Strategic Focus Areas:** Sagility is concentrating on enhancing operational efficiencies and exploring cross-selling opportunities post-acquisition of BroadPath, suggesting an ongoing shift towards diversifying client segments into mid-market areas.

7. **Investor Insight:** Given the strong financial metrics and growth potential driven by strategic acquisitions and operational excellence, the outlook remains positive, suggesting a favorable position for investors considering holding or accumulating shares in the company.